MannKind Corp. Posts Wider Loss In Q4 - Quick Facts

MannKind Corp. (MNKD) reported a fourth-quarter net loss of $14.3 million, or $0.07 per share compared to a loss of $9.8 million or $0.06 per share, a year ago. On average, five analysts polled by Thomson Reuters expected the company to report a loss per share of $0.07, for the quarter. Analysts' estimates typically exclude special items. The company said the increase in the net loss was primarily the result of an increased loss on foreign currency translation associated with its insulin supply agreement and of an increase in interest expense.

Fourth-quarter total revenues were $15.99 million, compared to $16.03 million, prior year. Analysts expected revenue of $15.04 million for the quarter. Afrezza net revenue increased 35%, primarily driven by higher product demand and price.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement. The U.S. Food and Drug Administration said it has taken steps to make available millions of cans of additional infant and specialty formula to U.S. consumers in the coming months. Under the agency's recent increased flexibilities, British nutrition products maker Kendal Nutricare will send about 2 million cans of infant formula under the Kendamil brand initially to U.S. beginning in June. Video streaming giant Netflix Inc. announced the availability of a variety of mobile games. Players can download the games directly from the Netflix mobile app. The new games include Dragon Up (East Side Games), Moonlighter (11 Bit Studios), Townsmen - A Kingdom Rebuilt (HandyGames), and Exploding Kittens - The Game (Exploding Kittens Digital).
Follow RTT